SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Jun-24 4:07 PM View: | Novavax, Inc. (NVAX) | 12-Jun-24 | Option Exercise | 6,670 | -- | -- | 54% 12.25K to 18.92K | |
02-Apr-24 4:05 PM View: | Glycomimetics Inc (GLYC) | 29-Mar-24 | Grant | 3,334 | $3.00 | $10,002.00 | < 1% 655.76K to 659.1K | |
02-Jan-24 4:05 PM View: | Glycomimetics Inc (GLYC) | 29-Dec-23 | Grant | 4,238 | $2.36 | $10,001.70 | < 1% 653.26K to 657.5K | |
03-Oct-23 4:05 PM View: | Glycomimetics Inc (GLYC) | 30-Sep-23 | Grant | 6,667 | $1.50 | $10,000.50 | 1% 646.6K to 653.26K | (11%) |
13-Jun-23 4:46 PM View: | Novavax, Inc. (NVAX) | 10-Jun-23 | Option Exercise | 3,100 | -- | -- | 39% 8.05K to 11.15K | |
06-Feb-23 10:00 PM View: | Glycomimetics Inc (GLYC) | 02-Aug-22 | txn.W.title | 7,500 | -- | -- | 1% 639.1K to 646.6K | |
21-Jun-22 8:46 PM View: | Novavax, Inc. (NVAX) | 17-Jun-22 | Option Exercise | 700 | -- | -- | 10% 7.35K to 8.05K | |
06-Feb-23 10:00 PM View: | Glycomimetics Inc (GLYC) | 15-Feb-22 | txn.W.title | 11,641 | -- | -- | 2% 627.46K to 639.1K | |
29-Jun-21 5:14 PM View: | Novavax, Inc. (NVAX) | 25-Jun-21 | Option Exercise | 6,900 | -- | -- | 138% 5.0K to 11.9K | |
21-May-21 5:06 PM View: | Novavax, Inc. (NVAX) | 19-May-21 | Market Purchase | 700 | $139.64 | $97,748.00 | 16% 4.3K to 5.0K | 5% |
22-Jan-21 4:00 PM View: | Glycomimetics Inc (GLYC) | 20-Jan-21 | Grant | 96,250 | -- | -- | 18% 531.21K to 627.46K | |
30-Dec-20 4:00 PM View: | Glycomimetics Inc (GLYC) | 28-Dec-20 | Option Exercise | 130,821 | $1.12 | $146,520.00 | 27% 484.56K to 615.38K | |
30-Dec-20 4:00 PM View: | Glycomimetics Inc (GLYC) | 28-Dec-20 | Market Option Sale (Planned) | 84,176 | $3.91 | $329,128.00 | (14%) 615.38K to 531.21K | 35% |
07-Aug-19 4:29 PM View: | Glycomimetics Inc (GLYC) | 06-Aug-19 | Option Exercise | 166,759 | $1.12 | $186,770.00 | 52% 317.8K to 484.56K | |
28-Mar-19 4:21 PM View: | Novavax, Inc. (NVAX) | 27-Mar-19 | Market Purchase | 42,000 | $0.53 | $22,251.60 | 100% 0 to 42.0K | < 1% |
28-Mar-19 4:21 PM View: | Novavax, Inc. (NVAX) | 27-Mar-19 | Market Purchase | 44,000 | $0.53 | $23,311.20 | 105% 42.0K to 86.0K | < 1% |
14-Feb-18 10:00 PM View: | Glycomimetics Inc (GLYC) | 08-Sep-17 | Gift | 46,602 | -- | -- | 13% 364.4K to 411.01K | |
14-Feb-18 10:00 PM View: | Glycomimetics Inc (GLYC) | 08-Sep-17 | Gift | 46,602 | -- | -- | (11%) 411.01K to 364.4K | |
26-Feb-15 5:02 PM View: | Glycomimetics Inc (GLYC) | 24-Feb-15 | Option Exercise | 50,000 | $1.12 | $56,000.00 | 19% 267.8K to 317.8K | |
20-Jun-14 4:00 PM View: | Glycomimetics Inc (GLYC) | 18-Jun-14 | Option Exercise | 100,000 | $1.12 | $112,000.00 | 60% 167.8K to 267.8K |